Pyone Myat Thu

515 total citations
9 papers, 330 citations indexed

About

Pyone Myat Thu is a scholar working on Molecular Biology, Pharmacology and Cell Biology. According to data from OpenAlex, Pyone Myat Thu has authored 9 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Cell Biology. Recurrent topics in Pyone Myat Thu's work include Cholesterol and Lipid Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Pyone Myat Thu is often cited by papers focused on Cholesterol and Lipid Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Pyone Myat Thu collaborates with scholars based in China. Pyone Myat Thu's co-authors include Xiaojun Xu, Zu‐Guo Zheng, Hui‐Jun Li, Ping Li, Yaping Zhou, Mu Zhang, Qian Cheng, Yanyan Wang, Qingling Liu and Hua Yang and has published in prestigious journals such as Cell Death and Differentiation, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

Pyone Myat Thu

9 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pyone Myat Thu China 8 194 65 51 46 43 9 330
Jie Xiao China 13 257 1.3× 61 0.9× 48 0.9× 38 0.8× 70 1.6× 21 553
Xiaoqin Zhong China 13 196 1.0× 66 1.0× 82 1.6× 41 0.9× 45 1.0× 38 490
Qing Sun China 11 251 1.3× 62 1.0× 67 1.3× 32 0.7× 37 0.9× 23 445
Jiankang Fang Macao 11 243 1.3× 73 1.1× 44 0.9× 42 0.9× 65 1.5× 16 484
Yilixiati Xiaokaiti China 13 227 1.2× 35 0.5× 43 0.8× 32 0.7× 31 0.7× 16 451
Rania M. Salama Egypt 13 198 1.0× 66 1.0× 59 1.2× 35 0.8× 40 0.9× 25 492
Yingping Wang China 9 232 1.2× 66 1.0× 65 1.3× 65 1.4× 42 1.0× 16 426
Zhongpeng Lu China 12 187 1.0× 59 0.9× 31 0.6× 33 0.7× 106 2.5× 17 418
Junyan Zhang China 13 248 1.3× 51 0.8× 32 0.6× 34 0.7× 43 1.0× 26 535
Chuanguo Liu China 12 201 1.0× 71 1.1× 33 0.6× 22 0.5× 46 1.1× 27 429

Countries citing papers authored by Pyone Myat Thu

Since Specialization
Citations

This map shows the geographic impact of Pyone Myat Thu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pyone Myat Thu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pyone Myat Thu more than expected).

Fields of papers citing papers by Pyone Myat Thu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pyone Myat Thu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pyone Myat Thu. The network helps show where Pyone Myat Thu may publish in the future.

Co-authorship network of co-authors of Pyone Myat Thu

This figure shows the co-authorship network connecting the top 25 collaborators of Pyone Myat Thu. A scholar is included among the top collaborators of Pyone Myat Thu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pyone Myat Thu. Pyone Myat Thu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liu, Xiaoxiao, Li Zhang, Pyone Myat Thu, et al.. (2020). Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53. Science China Life Sciences. 64(8). 1295–1310. 13 indexed citations
2.
Zheng, Zu‐Guo, Huimin Cheng, Yaping Zhou, et al.. (2020). Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss. Cell Death and Differentiation. 27(7). 2048–2065. 44 indexed citations
3.
Zheng, Zu‐Guo, Xin Zhang, Gang Cheng, et al.. (2020). Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway. Autophagy. 17(7). 1592–1613. 68 indexed citations
4.
Thu, Pyone Myat, Zu‐Guo Zheng, Yanyan Wang, et al.. (2019). Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis. European Journal of Pharmacology. 850. 23–34. 27 indexed citations
5.
Zhang, Mu, Qian Cheng, Zu‐Guo Zheng, et al.. (2018). Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway. Theranostics. 8(15). 4262–4278. 98 indexed citations
6.
Zheng, Zu‐Guo, Chong Lu, Pyone Myat Thu, et al.. (2018). Praeruptorin B improves diet-induced hyperlipidemia and alleviates insulin resistance via regulating SREBP signaling pathway. RSC Advances. 8(1). 354–366. 4 indexed citations
7.
Zheng, Zu‐Guo, Yaping Zhou, Chong Lu, et al.. (2017). Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice. European Journal of Pharmacology. 809. 156–162. 36 indexed citations
8.
Zhang, Mu, Fei Qian, Qingling Liu, et al.. (2017). Evaluation of structure–activity relationships of ginsenosides against amyloid β induced pathological behaviours in transgenic Caenorhabditis elegans. RSC Advances. 7(64). 40095–40104. 9 indexed citations
9.
Zheng, Zu‐Guo, Yaping Zhou, Xin Zhang, et al.. (2016). Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation. Biochemical Pharmacology. 122. 42–61. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jie Xiao Breakdown of academic impact, for papers by Xiaoqin Zhong Breakdown of academic impact, for papers by Qing Sun Breakdown of academic impact, for papers by Jiankang Fang Breakdown of academic impact, for papers by Yilixiati Xiaokaiti Breakdown of academic impact, for papers by Rania M. Salama Breakdown of academic impact, for papers by Yingping Wang Breakdown of academic impact, for papers by Zhongpeng Lu Breakdown of academic impact, for papers by Junyan Zhang Breakdown of academic impact, for papers by Chuanguo Liu
Rankless by CCL
2026